Biosyntech (Biosyntech) Short-Term Capital Lease Obligation

: $0.00 Mil (As of Dec. 2009)

View and export this data going back to 2000. Start your Free Trial

Biosyntech's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2009 was $0.00 Mil.

Biosyntech's quarterly Short-Term Capital Lease Obligation increased from Jun. 2009 ($9.10 Mil) to Sep. 2009 ($11.21 Mil) but then declined from Sep. 2009 ($11.21 Mil) to Dec. 2009 ($0.00 Mil).

Biosyntech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Biosyntech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

Short-Term Capital Lease Obligation

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
Short-Term Capital Lease Obligation																-	-	9.10	11.21	-

Biosyntech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Biosyntech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Biosyntech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines